# EDGAR Filing Document

**Accession Number:** 0001837821
**File Stem:** 0000000000-23-002093
**Filing Date:** 2023-3
**Character Count:** 5622
**Document Hash:** 8c54b303f125ce6457a56a2cfb7f12ef
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-23-002093.hdr.sgml**: 20230425

**ACCESSION NUMBER**: 0000000000-23-002093

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230302

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Jin Medical International Ltd.
- **CENTRAL INDEX KEY:** 0001837821
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** UPLOAD

**BUSINESS ADDRESS:**
- **STREET 1:** NO. 33 LINGXIANG ROAD, WUJIN DISTRICT
- **STREET 2:** CHANGZHOU CITY
- **CITY:** JIANGSU PROVINCE
- **STATE:** F4
- **ZIP:** 213149
- **BUSINESS PHONE:** (86)51989607972

**MAIL ADDRESS:**
- **STREET 1:** NO. 33 LINGXIANG ROAD, WUJIN DISTRICT
- **STREET 2:** CHANGZHOU CITY
- **CITY:** JIANGSU PROVINCE
- **STATE:** F4
- **ZIP:** 213149
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001213900-20-044524

## Text-Extract

```

United States securities and exchange commission logo

                              March 2, 2023

       Erqi Wang
       Chief Executive Officer
       Jin Medical International Ltd.
       No. 33 Lingxiang Road, Wujin District
       Changzhou City, Jiangsu Province
       People   s Republic of China

                                                        Re: Jin Medical
International Ltd.
                                                            Amendment No. 11 to
Registration Statement on Form F-1
                                                            Filed February 24,
2023
                                                            File No. 333-259767

       Dear Erqi Wang:

             We have reviewed your amended registration statement and have the
following
       comments. In some of our comments, we may ask you to provide us with
information so we
       may better understand your disclosure.

              Please respond to this letter by amending your registration
statement and providing the
       requested information. If you do not believe our comments apply to your
facts and
       circumstances or do not believe an amendment is appropriate, please tell
us why in your
       response.

              After reviewing any amendment to your registration statement and
the information you
       provide in response to these comments, we may have additional comments.

       Amendment No. 11 to Form F-1 filed February 24, 2023

       Exhibits

   1.                                                   We refer to your filing
tee table filed as Exhibit 107 to your registration statement. Please
                                                        revise your filing fee
table to include separate entries for the Underwriters' Warrants and
                                                        the ordinary shares
underlying such warrants.
              You may contact Jeanne Baker at 202-551-3691 or Terence O'Brien
at 202-551-3355 if
       you have questions regarding comments on the financial statements and
related matters. Please
       contact Jane Park at 202-551-7439 or Celeste Murphy at 202-551-3257 with
any other questions.
 Erqi Wang
Jin Medical International Ltd.
March 2, 2023
Page 2
                                              Sincerely,

FirstName LastNameErqi Wang                   Division of Corporation Finance
                                              Office of Industrial Applications
and
Comapany NameJin Medical International Ltd.
                                              Services
March 2, 2023 Page 2
cc:       Ying Li, Esq.
FirstName LastName

```

### Attached PDF Documents

**Attachment 1:** `filename1`

![img-0.jpeg](img-0.jpeg)

CORPORATION FINANCE

# UNITED STATES  
SECURITIES AND EXCHANGE COMMISSION  
WASHINGTON, D.C. 20549

March 2, 2023

Erqi Wang  
Chief Executive Officer  
Jin Medical International Ltd.  
No. 33 Lingxiang Road, Wujin District  
Changzhou City, Jiangsu Province  
People's Republic of China

**Re: Jin Medical International Ltd.**

**Amendment No. 11 to Registration Statement on Form F-1**

**Filed February 24, 2023**

**File No. 333-259767**

Dear Erqi Wang:

We have reviewed your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure.

Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response.

After reviewing any amendment to your registration statement and the information you provide in response to these comments, we may have additional comments.

Amendment No. 11 to Form F-1 filed February 24, 2023

# Exhibits

1. We refer to your filing fee table filed as Exhibit 107 to your registration statement. Please revise your filing fee table to include separate entries for the Underwriters' Warrants and the ordinary shares underlying such warrants.

You may contact Jeanne Baker at 202-551-3691 or Terence O'Brien at 202-551-3355 if you have questions regarding comments on the financial statements and related matters. Please contact Jane Park at 202-551-7439 or Celeste Murphy at 202-551-3257 with any other questions.

Erqi Wang  
Jin Medical International Ltd.  
March 2, 2023  
Page 2

Sincerely,

Division of Corporation Finance  
Office of Industrial Applications and  
Services

cc: Ying Li, Esq.